SUCRALFATE CAUSES MALABSORPTION OF L-THYROXINE

被引:75
作者
SHERMAN, SI
TIELENS, ET
LADENSON, PW
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV ENDOCRINOL & METAB,BALTIMORE,MD
[2] JOHNS HOPKINS THYROID TUMOR CTR,BALTIMORE,MD
关键词
D O I
10.1016/0002-9343(94)90093-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: To determine if sucralfate causes malabsorption of L-thyroxine. PATIENTS AND METHODS: Five healthy volunteers ingested L-thyroxine, 1,000 mu g, administered orally (1) without sucralfate, (2) with sucralfate, 1 g, and (3) 8 hours after sucralfate, 2 g. The amount of L-thyroxine absorbed was calculated from the peak increase in serum T-4 levels within 6 hours of hormone ingestion multiplied by the volume of distribution for the hormone. RESULTS: Peak absorption of L-thyroxine in the absence of sucralfate was 796 mu g (95% confidence interval (CI): 515 - 1,074 mu g). Coadministration of sucralfate, 1 g, with L-thyroxine reduced thyroid hormone absorption to 225 mu g (95% CI: 151 - 299 mu g) (P = 0.0029 compared with control). Peak hormone absorption was delayed 2 hours by simultaneous sucralfate ingestion. Separation of administered L-thyroxine and sucralfate doses by 8 hours returned hormone absorption to control values. Maximum T-3 levels did not differ, regardless of drug regimen, but suppression of thyroid-stimulating hormone (TSH) by L-thyroxine was reduced by coadministration of sucralfate. CONCLUSIONS: Sucralfate causes malabsorption of L-thyroxine, presumably by intraluminal binding of hormone.
引用
收藏
页码:531 / 535
页数:5
相关论文
共 19 条
[1]   PSEUDOMALABSORPTION OF LEVOTHYROXINE [J].
AIN, KB ;
REFETOFF, S ;
FEIN, HG ;
WEINTRAUB, BD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (15) :2118-2120
[2]  
ARMITAGE P, 1987, STATISTICAL METHODS
[3]   CLINICAL EFFICACY OF SUCRALFATE IN THE TREATMENT OF GASTRIC-ULCER [J].
ASAKA, M ;
TAKEDA, H ;
SAITO, M ;
MURASHIMA, Y ;
MIYAZAKI, T .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S71-S73
[4]   FERROUS SULFATE REDUCES THYROXINE EFFICACY IN PATIENTS WITH HYPOTHYROIDISM [J].
CAMPBELL, NRC ;
HASINOFF, BB ;
STALTS, H ;
RAO, B ;
WONG, NCW .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (12) :1010-1013
[5]  
CHUNG SJ, 1964, ENDOCRINOLOGY, V74, P694
[6]   RAT ENTEROHEPATIC CIRCULATION AND INTESTINAL DISTRIBUTION OF ENTERALLY INFUSED THYROID-HORMONES [J].
DISTEFANO, JJ ;
STERNLICHT, M ;
HARRIS, DR .
ENDOCRINOLOGY, 1988, 123 (05) :2526-2539
[7]   REPLACEMENT DOSE, METABOLISM, AND BIOAVAILABILITY OF LEVOTHYROXINE IN THE TREATMENT OF HYPOTHYROIDISM - ROLE OF TRIIODOTHYRONINE IN PITUITARY FEEDBACK IN HUMANS [J].
FISH, LH ;
SCHWARTZ, HL ;
CAVANAUGH, J ;
STEFFES, MW ;
BANTLE, JP ;
OPPENHEIMER, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (13) :764-770
[8]  
GREENSTADT MA, 1982, HORMONE DRUGS, P534
[9]   LEVOTHYROXINE BINDING BY SUCRALFATE [J].
HAVRANKOVA, J ;
LAHAIE, R .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (05) :445-446
[10]   ABSORPTION OF ORAL THYROXINE IN MAN [J].
HAYS, MT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1968, 28 (06) :749-+